ReviewTranslational cancer research2020

Current perspectives on novel systemic therapeutic agents beyond immune checkpoint inhibition in metastatic urothelial carcinoma.

Hoon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.